Skip to content

Open-label PrEP in Botswana: very high adherence and no HIV infections seen

Faith Henderson at IAS 2015 photo ©Marcus Rose/IAS

PrEP demo project finds the people at highest HIV risk generally take PrEP most consistently

Albert Liu at IAS 2015. Photo by Liz Highleyman, hivandhepatitis,com

Gay youth PrEP study finds good retention and reasonable adherence

Sybil Hosek at IAS 2015 photo ©Marcus Rose/IAS

Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain

The pros and cons of PrEP: trial volunteers recount their experience of the ADAPT study

PrEP symposium panel at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com.

Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing

Tim Holtz and Sharon Mannheimer at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide

Conference co-chair, Julio Montaner, at the Opening Session of IAS 2015, with a Native blanket received as a gift. Photo ©Steve Forrest/Workers' Photos/IAS

Black market for Truvada PrEP may undermine treatment adherence in marginalised people living with HIV

Where next in PrEP and microbicides? Europeans discuss research pipeline